Out-of-Hospital 30-Day Mortality After Mitral TEER: Insights From the STS/ACC TVT Registry

Keyphrases

• All-cause Mortality 100%
• 30-day Mortality 100%
• TVT Registry 100%
• Out-of-hospital Mortality 100%
• Mitral TEER 100%
• Cardiovascular Mortality 66%
• Median Time 33%
• Hispanic Ethnicity 33%
• Old Age 33%
• Improved Outcomes 33%
• Hemoglobin 33%
• Left Ventricular Ejection Fraction 33%
• Logistic Regression Analysis 33%
• Non-Hispanic 33%
• Mitral Valve 33%
• Society of Thoracic Surgeons 33%
• ST-elevation Myocardial Infarction (STEMI) 33%
• Survival Analysis 33%
• In-hospital Complications 33%
• Health Status 33%
• Procedural Complications 33%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 33%
• White Race 33%
• Resource Utilization 33%
• Being Adopted 33%
• Transcatheter Edge-to-edge Repair 33%
• Modifiable Factors 33%
• Baseline Health 33%
• High Acuity 33%
• Transcatheter Valve Therapy Registry 33%
• Guideline-directed Medical Therapy 33%
• Recurrent Mitral Regurgitation 33%
• Patient Selection Guidelines 33%

Medicine and Dentistry

• All Cause Mortality 100%
• Hospital Mortality 75%
• Cardiovascular Mortality 50%
• Heart Left Ventricle Ejection Fraction 25%
• Surgeon 25%
• Myocardial Infarction 25%
• Mitral Valve 25%
• Logistic Regression Analysis 25%
• Patient Selection 25%
• Mitral Insufficiency 25%
• Health Status 25%
• Survival Analysis 25%
• ACE Inhibitor 25%
• Angiotensin Receptor Antagonist 25%
• Hemoglobins 25%
• Cardiovascular System 25%